Results 151 to 160 of about 43,704 (225)

Short-course high-dose cytarabine consolidation therapy before allogeneic hematopoietic stem cell transplantation improves 2-year relapse-free survival but not overall survival in patients with acute myeloid leukemia: a single-center retrospective study. [PDF]

Ann Hematol
Ma Y, Cheng Y, Sun Y, Zhu X, Zhang H, Dhurel RS, Zhang H, Sun Q, Liu Q, Chen W, Cheng H, Li Z, Pan B, Yan Z.   +13 more
europepmc   +1 more source

A proposed refined definition of acute myeloid leukaemia patients ineligible for intensive therapy: The Integrated Comorbidity–ECOG–Age criteria

British Journal of Haematology, Volume 209, Issue 2, Page 809-811, August 2026.
Daniel Weidl, Myrto Boukovala, Doris Glaser, Bettina Barthel, Lars Bullinger, Michael Heuser   +5 more
wiley   +1 more source

Chidamide combined with decitabine, venetoclax, and low-dose cytarabine for relapsed/refractory acute myeloid leukemia: a single-center case series. [PDF]

Front Oncol
Li Q, Ji J, Wu Y.
europepmc   +1 more source

Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final analysis of the phase 3 SYMPATICO study

British Journal of Haematology, Volume 209, Issue 2, Page 734-739, August 2026.
Michael Wang, Wojciech Jurczak, Marek Trneny, David Belada, Tomasz Wrobel, Nilanjan Ghosh, Mary‐Margaret Keating, Tom van Meerten, Ruben Fernandez Alvarez, Gottfried von Keudell, Catherine Thieblemont, Frederic Peyrade, Marc Andre, Marc Hoffmann, Edith Szafer‐Glusman, Jennifer Lin, James P. Dean, Jutta K. Neuenburg, Constantine S. Tam   +18 more
wiley   +1 more source

Integrated Molecular Risk Stratification and Measurable Residual Disease-Guided Consolidation Improve Outcomes in Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia. [PDF]

Cancer Med
Cai C, Chen Y, Wu C, Feng X, Li C, Zheng M, Mai H, Yang L, Jiang H, He X, Wen H, Xu H, Chen C, Le S, Li N, Zheng Y.   +15 more
europepmc   +1 more source

Improved outcomes of the refined risk-stratification and risk-adapted therapy in children with acute myeloid leukemia: final results of the AIEOP AML 2013. [PDF]

J Hematol Oncol
Locatelli F, Buldini B, Pigazzi M, Rizzari C, Menna G, Fagioli F, Tumino M, Lo Nigro L, D'Angelo P, Cefalo MG, Paganelli V, Strocchio L, Becilli M, Spinelli M, Giagnuolo G, Saglio F, Santoro N, Micalizzi C, Zecca M, Masetti R, Merli P.   +20 more
europepmc   +1 more source

Anaplastic Large Cell Lymphoma in Children: 20-Year Immune-Oriented Treatment Experience. [PDF]

Cancers (Basel)
Volkova AS, Valiev TT, Kiselevskiy MV, Shubina IZ, Kirgizov KI, Varfolomeeva SR, Stilidi IS.   +6 more
europepmc   +1 more source

Autologous bone marrow transplantation in non-Hodgkin lymphoma patients following different conditioning regimens: an 11-year single-center quasi-experimental study. [PDF]

Blood Res
Tavakoli Shiraji S, Biglari M, Rad S, Barkhordar M, Foumani HK, Janbabaei G, Mousavi SA, Vaezi M, Mohammadi K, Ghavamzadeh A.   +9 more
europepmc   +1 more source

Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial. [PDF]

Blood Cancer Discov
Senapati J, Kantarjian HM, Ayoub E, Quesada AE, Loghavi S, Sasaki K, Kadia TM, Daver N, DiNardo CD, Jain A, McCabe M, Haddad FG, Brandt M, Tang G, Alvarado Y, Farish K, Abbas HA, Garcia-Manero G, Ravandi F, Andreeff M, Borthakur G.   +20 more
europepmc   +1 more source

Clinico-genomic characterization of RAS-mutant acute myeloid leukemia. [PDF]

Ann Hematol
Yuan R, Xie Y, Miron PM, Higgins AW, Hutchinson L, Cerny J, Patel SA.   +6 more
europepmc   +1 more source